Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Curran

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Cancer Journal (Sudbury, Mass.)|January 24, 2018
Preclinical Data Supporting Antitumor Activity of PD-1 BlockadeMichael A Curran
Frontiers in Oncology|June 25, 2015
4-1BB Agonists: Multi-Potent Potentiators of Tumor ImmunityTodd Bartkowiak, Michael A Curran
Seminars in Cancer Biology|January 27, 2020
Tumor hypermetabolism confers resistance to immunotherapyArthur Liu, Michael A Curran
Frontiers in Oncology|April 1, 2025
The influence of the microbiome on radiotherapy and DNA damage responsesAadil Sheikh, Michael A Curran
Cancer Immunology, Immunotherapy : CII|January 4, 2015
Immune checkpoint combinations from mouse to manMidan Ai, Michael A Curran
Annual Review of Medicine|November 1, 2018
New Hope for Therapeutic Cancer Vaccines in the Era of Immune Checkpoint ModulationMichael A Curran, Bonnie S Glisson
Methods in Molecular Medicine|May 4, 2002
Recombinant feline immunodeficiency virus vectors. Preparation and useMichael A Curran, Garry P Nolan
Cancer Research|September 10, 2009
Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumorsMichael A Curran, James P Allison
Journal of Neuroscience Methods|February 20, 2022
Method of long-term, recurrent, intracerebroventricular infusion of cellular therapy in miceChao-Hsien Chen, Michael A Curran
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2004
Lentiviral vectors for the delivery of DNA into mammalian cellsRoland Wolkowicz, Garry P Nolan, Michael A Curran
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Cancer Journal (Sudbury, Mass.)|January 24, 2018
Preclinical Data Supporting Antitumor Activity of PD-1 BlockadeMichael A Curran
Frontiers in Oncology|June 25, 2015
4-1BB Agonists: Multi-Potent Potentiators of Tumor ImmunityTodd Bartkowiak, Michael A Curran
Seminars in Cancer Biology|January 27, 2020
Tumor hypermetabolism confers resistance to immunotherapyArthur Liu, Michael A Curran
Frontiers in Oncology|April 1, 2025
The influence of the microbiome on radiotherapy and DNA damage responsesAadil Sheikh, Michael A Curran
Cancer Immunology, Immunotherapy : CII|January 4, 2015
Immune checkpoint combinations from mouse to manMidan Ai, Michael A Curran
Annual Review of Medicine|November 1, 2018
New Hope for Therapeutic Cancer Vaccines in the Era of Immune Checkpoint ModulationMichael A Curran, Bonnie S Glisson
Methods in Molecular Medicine|May 4, 2002
Recombinant feline immunodeficiency virus vectors. Preparation and useMichael A Curran, Garry P Nolan
Cancer Research|September 10, 2009
Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumorsMichael A Curran, James P Allison
Journal of Neuroscience Methods|February 20, 2022
Method of long-term, recurrent, intracerebroventricular infusion of cellular therapy in miceChao-Hsien Chen, Michael A Curran
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2004
Lentiviral vectors for the delivery of DNA into mammalian cellsRoland Wolkowicz, Garry P Nolan, Michael A Curran
Pageof 9